Table 1. Mean CHADS 2 score, proportion... | American Society of Hematology

Table 1.

Mean CHADS₂ score, proportion of patients with prior stroke, and dosing regimen in the trials analyzed by Yoshioka et al

Trial	Oral FXa inhibitors	Regimen	Mean CHADS₂ score	Proportion of patients with prior stroke, %
J-ROCKET AF²²	Rivaroxaban	15 mg once per d	3.3	64
ROCKET AF²⁴	Rivaroxaban	20 mg once per d	3.5	55
ENGAGE²⁰	Edoxaban	60 mg once per d	2.8	28
ARISTOTLE²¹	Apixaban	5 mg twice per d	2.1	19
AVERROES¹⁹	Apixaban	5 mg twice per d	2.0	14

Trial	Oral FXa inhibitors	Regimen	Mean CHADS₂ score	Proportion of patients with prior stroke, %
J-ROCKET AF²²	Rivaroxaban	15 mg once per d	3.3	64
ROCKET AF²⁴	Rivaroxaban	20 mg once per d	3.5	55
ENGAGE²⁰	Edoxaban	60 mg once per d	2.8	28
ARISTOTLE²¹	Apixaban	5 mg twice per d	2.1	19
AVERROES¹⁹	Apixaban	5 mg twice per d	2.0	14